Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Adverse Business Impact

Medplus Health Services Adverse Business Impact

Optival Health Solutions, a subsidiary, received a one-day drug license suspension from the Drugs Control Administration for a violation of the Drugs and Cosmetics Act.

Key figures
Value₹0.00 Cr
Order fromThe Assistant Director Drugs Control Administration, Telangana
Execution period01 day
Source

BSE filing, NSE: MEDPLUS. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Medplus Health Services Ltd: key numbers

Share price
₹609.40
Market cap
₹7,321 Cr
Revenue (annual)
₹6,892 Cr
Net profit (annual)
₹219.7 Cr
P/E (TTM)
34.7×Sector 52.0×
Promoter holding
40.19%+0.00% QoQ
FII holding
12.58%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Medplus Health Services Ltd

All →

Other adverse business impact announcements

All →